INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

182 studies · page 3 of 8

2020 / Systematic review and meta-analysis of RCTs

Yoga significantly reduced fatigue compared to typical care in patients with multiple sclerosis, but did not significantly affect quality of life.

A systematic review and meta-analysis of 10 randomized controlled trials evaluated the effect of yoga on fatigue and quality of life in 693 patients with multiple sclerosis. Yoga intervention improved fatigue significantly compared to typical MS care (SMD = -0.872; 95% CI: -1.467 to -0.277, p = 0.004), with no significant difference when compared to exercise (SMD = -0.093; 95% CI: -0.353 to 0.167, p = 0.482). Yoga did not show significant effects compared to typical care or exercise on overall quality of life, physical or psychological components, sexual function, or cognitive function.

Shohani M, Kazemi F, Rahmati S, et al. Complement Ther Clin Pract, 2020. PMID 32379628

2020 / Systematic review and meta-analysis of RCTs/CCTs

Dietary interventions including PUFAs and antioxidants show uncertain or little to no effect on multiple sclerosis relapses or disability progression.

A Cochrane systematic review evaluated 30 trials covering PUFA supplementation, antioxidants, dietary programs, and other supplements for multiple sclerosis. Comparing PUFAs with MUFAs showed very uncertain evidence regarding relapses (RR 1.02, 95% CI 0.88 to 1.20; 3 studies, 217 participants) and low-certainty evidence of little to no difference in global impression of deterioration (RR 0.85, 95% CI 0.71 to 1.03; 4 studies, 542 participants). Antioxidant supplementation compared to placebo also showed little to no difference in relapses (RR 0.98, 95% CI 0.59 to 1.64; 4 studies, 345 participants) and very uncertain effects on EDSS change (MD -0.19, 95% CI -0.49 to 0.11; 6 studies, 490 participants). All included trials had at least one methodological issue leading to unknown or high risk of bias.

Parks NE, Jackson-Tarlton CS, Vacchi L, et al. Cochrane Database Syst Rev, 2020. PMID 32428983

2020 / Systematic review and meta-analysis of clinical trials

Music therapy improved cognitive function, immediate quality of life, and long-term depression in people with dementia.

A systematic review and meta-analysis evaluated the effect of music therapy in people living with dementia using data from eight studies of acceptable quality. The meta-analysis showed that music intervention improved cognitive function, quality of life immediately after the intervention, and long-term depression. However, no evidence was found for improvement in long-term quality of life or short-term depression.

Moreno-Morales C, Calero R, Moreno-Morales P, et al. Front Med (Lausanne), 2020. PMID 32509790

2020 / Meta-meta-analysis of 5 meta-analyses (100 primary studies)

In a meta-meta-analysis, overall cholesterol and LDL-C levels were linked to Alzheimer's disease risk, while HDL-C, TC, and TG showed no significant link.

Researchers conducted a meta-meta-analysis across multiple databases to determine the relationship between cholesterol markers and Alzheimer's disease (AD) risk. Five meta-analyses comprising 100 primary studies were analyzed. The total effect of cholesterol on the risk of AD was significant and heterogeneous. Subgroup analysis showed that LDL-C levels influenced the development of AD, whereas non-significant effects were found for HDL-C, total cholesterol (TC), and triglyceride (TG) levels.

Shows an association, not proof of cause and effect.

Sáiz-Vazquez O, Puente-Martínez A, Ubillos-Landa S, et al. Brain Sci, 2020. PMID 32570800

2020 / Systematic review and meta-analysis

Ginkgo biloba preparation was associated with improved cognitive function and global clinical assessment in Alzheimer disease patients.

A systematic review and meta-analysis of seven studies (N = 939) evaluated the efficacy and safety of Ginkgo biloba preparation for treating Alzheimer disease. Compared with placebo, Ginkgo biloba demonstrated benefits in cognitive function (risk ratio = 1.98, 95% confidence interval = 1.52-2.59, Z = 5.12, P < 0.001) and global clinical assessment via Clinical Global Impression Change (odds ratio = 3.119, 95% confidence interval = 2.206-4.410, Z = 6.44, P < 0.001). Adverse events were reported as mild.

Liao Z, Cheng L, Li X, et al. Clin Neuropharmacol, 2020. PMID 32658034

2020 / Systematic review and meta-analysis of RCTs

A meta-analysis of RCTs found no significant effect of probiotics, prebiotics, or fermented foods on global cognition or specific cognitive domains.

A systematic review and meta-analysis evaluated 22 RCTs (n = 1551) assessing probiotics (11 studies, n = 724), prebiotics (5 studies, n = 355), and fermented foods (6 studies, n = 472) for cognitive performance. Pooled analysis found no significant effect on global cognition for probiotics (g = 0.115, 95% CI -0.041 to 0.270, p = 0.148), prebiotics (g = 0.077, 95% CI -0.091 to 0.246, p = 0.369), or fermented food (g = 0.164, 95% CI -0.017 to 0.345, p = 0.076), nor for any individual cognitive domain. Most studies (16 of 22) showed low risk of bias, but results do not support these interventions for cognitive outcomes, potentially due to small, short-term trials and clinical heterogeneity.

Marx W, Scholey A, Firth J, et al. Neurosci Biobehav Rev, 2020. PMID 32860802

2020 / Systematic review of clinical trials

A systematic review of five clinical trials found sulforaphane use was positively correlated with improved behavior and cognitive function in ASD.

This systematic review assessed sulforaphane therapy as a treatment for individuals with autism spectrum disorder across multiple databases. All five included clinical trials reported a significant positive correlation between sulforaphane use and ASD behavior and cognitive function. The authors noted minimal side effects and concluded sulforaphane appears safe and effective for treating ASD.

McGuinness G, Kim Y EXCLI J, 2020. PMID 33013262

2020 / Systematic review of reviews

Physical activity improves quality of life and well-being across adults, with benefits also noted in certain psychiatric and neurologic conditions.

This systematic review examined the relationship between physical activity and quality of life and well-being using systematic reviews, meta-analyses, and pooled analyses published from 2006 to 2018. Strong evidence, predominantly from RCTs, showed that physical activity improves QoL and well-being in adults aged 18-65 years and older adults compared with minimal or no-treatment controls. Moderate evidence indicated improvements in individuals with schizophrenia and Parkinson's disease, while limited evidence supported improvements in youth and adults with major clinical depression or bipolar disorder. Evidence was insufficient for individuals with dementia due to a small number of studies with mixed results.

Marquez DX, Aguiñaga S, Vásquez PM, et al. Transl Behav Med, 2020. PMID 33044541

2020 / Systematic review and meta-analysis of randomized controlled trials

Exercise interventions improved cognitive function and handgrip strength in older adults with mild cognitive impairment.

A systematic review and meta-analysis of 14 randomized controlled trials was conducted to evaluate the effects of exercise in 1,178 older adults with mild cognitive impairment (MCI). Exercise participation improved cognitive functions (d = 0.88, 95% CI: 0.10-1.65, p = 0.01; k = 5) and handgrip strength (d = 0.62, 95% CI: 0.23-1.01, p = 0.00; k = 4) compared with control groups. Moderate to vigorous aerobic or resistance exercise for at least 150 minutes, 1 time per week for 6 weeks, was the minimum level observed to yield beneficial effects. The authors noted that further studies are needed to confirm these effects.

Lee J Int J Environ Res Public Health, 2020. PMID 33317169

2020 / Systematic review of randomized controlled trials

Souvenaid dietary supplement probably results in little to no difference in cognitive function or dementia progression in Alzheimer's disease.

A systematic review evaluated three randomized, placebo-controlled trials examining the dietary supplement Souvenaid in 1,097 participants with Alzheimer's disease (AD). In prodromal AD, Souvenaid showed little to no difference compared to placebo in the incidence of dementia after 24 months (RR 1.09, 95% CI 0.82 to 1.43). Across prodromal, mild, and mild-to-moderate AD, it probably resulted in little to no difference in global or specific cognitive functions or activities of daily living. A slight improvement on the Clinical Dementia Rating Sum of Boxes was observed in prodromal AD after 24 months, but this was below estimates of meaningful change. Adverse effects were low across trials, and two of the three included studies were funded by the manufacturer.

Burckhardt M, Watzke S, Wienke A, et al. Cochrane Database Syst Rev, 2020. PMID 33320335

2019 / Systematic review and meta-analysis of randomized controlled trials

A meta-analysis found curcumin improved cognitive scores in older adults, while treated Alzheimer's patients showed a trend to do worse than placebo on the MMSE.

A systematic review and meta-analysis of six randomized controlled trials totaling 289 subjects evaluated curcumin for cognitive function. For older adults, curcumin improved cognitive function scores (SMD = 0.33, 95% CI [0.05, 0.62]; p = 0.02), with adverse events OR = 5.59 (95% CI [0.96, 36.80]; p = 0.05) and depression measures SMD = -0.29 (95% CI [0.64, 0.05]; p = 0.09). In Alzheimer's disease patients, cognition scores indicated a trend for treated subjects to do worse than placebo on the Mini-Mental State Examination (SMD = -0.90, 95% CI [1.48, -0.32]; p = 0.002). Limitations noted were a small number of studies, preventing funnel plot or sensitivity analysis, and insufficient data for schizophrenia outcomes.

Zhu LN, Mei X, Zhang ZG, et al. Phytother Res, 2019. PMID 30575152

2019 / Systematic review and meta-analysis of randomized controlled trials

Exercise improved cognitive domains in older adults, with shorter, more frequent sessions predicting higher effects in those with cognitive impairment.

This systematic review and meta-analysis evaluated the dose-response relationship between exercise and cognitive function in older adults. In healthy older adults (n = 23 studies), exercise had small positive effects on executive function (d = 0.27) and memory (d = 0.24), though dose parameters did not predict effect size magnitude. In older adults with cognitive impairments (n = 13 studies), exercise exerted a moderate positive effect on global cognition (d = 0.37), and programs with short session duration and high frequency predicted higher effect sizes (d = 0.43-0.50). The authors note that studies directly comparing different exercise doses are needed.

Sanders LMJ, Hortobágyi T, la Bastide-van Gemert S, et al. PLoS One, 2019. PMID 30629631

2019 / Systematic review and meta-analysis of randomized controlled trials

Dietary interventions significantly reduced depressive symptoms but had no significant effect on anxiety in a meta-analysis of randomized controlled trials.

A meta-analysis of 16 randomized controlled trials evaluated the effects of dietary interventions on depression and anxiety symptoms in 45,826 participants, primarily with nonclinical depression. Dietary improvement significantly reduced depressive symptoms compared to controls (g = 0.162, 95% CI: 0.055 to 0.269, p = 0.003), with similar effects observed in high-quality trials and against both active and inactive controls. No significant effect was found for anxiety symptoms (k = 11, n = 2,270, g = 0.085, 95% CI: -0.031 to 0.202, p = 0.151). Studies with female samples observed significantly greater benefits for both depression and anxiety symptoms.

Firth J, Marx W, Dash S, et al. Psychosom Med, 2019. PMID 30720698

2019 / Systematic review of controlled studies

Nature interventions show a significant effect on mental well-being in somatic patients.

A systematic review assessed five controlled quantitative studies investigating nature-based programs among individuals with physical conditions. Across four studies involving somatic illnesses, a significant benefit on self-reported psychological measures was identified. Conversely, the single study evaluating individuals with psychosomatic illness showed no significant benefit, leaving results for that subgroup inconclusive.

Trøstrup CH, Christiansen AB, Stølen KS, et al. Qual Life Res, 2019. PMID 30746588

2019 / Umbrella review of observational studies

Fruit and vegetable intake shows probable evidence for cardiovascular disease protection in reviews.

An umbrella review examined quantitative syntheses of observational studies linking produce intake with health outcomes. Probable evidence was observed for cardiovascular protection, while possible evidence indicated lower risks of colon malignancies, depressive disorders, and pancreatic ailments for fruits. For vegetable consumption, possible evidence supported lower risks of stroke, hip fractures, colorectal malignancies, depression, and pancreatic conditions, though geographical location and sex were potential confounding factors.

Shows an association, not proof of cause and effect.

Angelino D, Godos J, Ghelfi F, et al. Int J Food Sci Nutr, 2019. PMID 30764679

2019 / Systematic review and meta-analysis of randomized controlled trials

Coenzyme Q10 and magnesium did not significantly reduce migraine frequency or severity.

A systematic review evaluated 18 randomized controlled trials testing vitamins and minerals for preventing migraines in adults. Meta-analyses found that coenzyme Q10 did not significantly reduce attack frequency (MD -0.44, 95% CI -2.14 to 1.26; 2 trials; 97 participants) or duration (MD -1.97, 95% CI -4.82 to 0.87; 2 trials; 97 participants). Likewise, magnesium did not significantly decrease migraine severity compared to placebo (ratio of means -0.17, 95% CI -0.36 to 0.02; 3 trials; 226 participants).

Okoli GN, Rabbani R, Kashani HH, et al. Can J Neurol Sci, 2019. PMID 30764890

2019 / Systematic review and meta-analysis

Mind-body therapies significantly improved sleep quality and reduced insomnia severity in adults, according to a meta-analysis.

A systematic review and meta-analysis of 49 studies published between 2004 and 2018 evaluated the effect of mind-body therapies (meditation, tai chi, qigong, yoga lasting 4 to 24 weeks) on sleep outcomes in 4,506 adults. Interventions yielded statistically significant improvements in sleep quality and reductions in insomnia severity, but had no significant effects on sleep quantity indices measured objectively or via sleep diaries. Qigong demonstrated a slight advantage over tai chi in improving sleep quality, and effects on sleep quality were larger in healthy individuals than in clinical populations. Authors noted that more high-quality and well-controlled RCTs are needed.

Wang X, Li P, Pan C, et al. Evid Based Complement Alternat Med, 2019. PMID 30894878

2019 / Systematic review and meta-analysis of RCTs

Yoga improves physical function and health-related quality of life outcomes compared to active and inactive controls in older adults.

A systematic review and meta-analysis evaluated 22 RCTs assessing the effects of yoga versus inactive or active controls on physical function and HRQoL in older adults (mean age >= 60). Compared with inactive controls, yoga significantly improved balance (ES = 0.7), lower body flexibility (ES = 0.5), lower limb strength (ES = 0.45), depression (ES = 0.64), perceived mental health (ES = 0.6), perceived physical health (ES = 0.61), sleep quality (ES = 0.65), and vitality (ES = 0.31). Compared with active controls, yoga significantly improved lower limb strength (ES = 0.49), lower body flexibility (ES = 0.28), and depression (ES = 0.54).

Sivaramakrishnan D, Fitzsimons C, Kelly P, et al. Int J Behav Nutr Phys Act, 2019. PMID 30953508

2019 / Systematic review and meta-analysis

Green exercise showed limited evidence of superior physical or mental health benefits

A systematic review evaluated 28 trials comparing outdoor or virtual green exercise with indoor exercise lacking nature views. A meta-analysis of three longitudinal studies revealed slightly reduced post-exercise perceived exertion with green exercise (mean difference: -1.02; 95% CI: -1.88, -0.16). Overall, evidence of superior health benefits was limited and characterized by high risk of bias across included trials.

Lahart I, Darcy P, Gidlow C, et al. Int J Environ Res Public Health, 2019. PMID 30991724

2019 / Systematic review and meta-analysis of trials

Forest bathing was associated with significantly lower salivary cortisol levels compared with urban environments.

A systematic review and meta-analysis evaluated the effect of forest bathing on salivary and serum cortisol levels. Across 22 included studies, almost all showed significantly lower cortisol or a significant pre-post reduction in forest groups compared with control groups. The meta-analysis of 8 studies found salivary cortisol levels were significantly lower in forest groups than urban groups both before (MD = -0.08 μg/dl [95% CI -0.11 to -0.05], p < 0.01) and after intervention (MD = -0.05 μg/dl [95% CI -0.06 to -0.04], p < 0.01). The authors note that anticipated placebo effects could play an important role and further research is advised due to limited available data.

Antonelli M, Barbieri G, Donelli D Int J Biometeorol, 2019. PMID 31001682

2019 / Prospective cohort study and meta-analysis of prospective cohort studies

Lower carbohydrate diets were linked to higher risks of overall, cardiovascular, and cancer mortality.

Researchers examined the link between low-carbohydrate diet (LCD) scores and mortality using NHANES (1999-2010) data and a pooled analysis of nine prospective cohort studies. In NHANES (24,825 participants), those in the lowest carbohydrate quartile had the highest risk of overall (32%), CVD (50%), cerebrovascular (51%), and cancer (36%) mortality compared to the highest carbohydrate intake quartile. In the pooled analysis of nine cohorts (462,934 participants), LCD was associated with higher overall (RR 1.22, 95% CI 1.06-1.39), CVD (RR 1.13, 95% CI 1.02-1.24), and cancer mortality (RR 1.08, 95% CI 1.01-1.14). The authors noted that causality cannot be proven and residual bias cannot be ruled out.

Shows an association, not proof of cause and effect.

Mazidi M, Katsiki N, Mikhailidis DP, et al. Eur Heart J, 2019. PMID 31004146

2019 / Systematic review and meta-analysis of prospective cohort studies

Higher saturated fat intake was linked to an increased risk of cognitive impairment and Alzheimer disease in older adults.

A systematic review and meta-analysis of 9 prospective cohort studies with 23,402 older participants evaluated dietary fat intake and cognitive outcomes. The highest category of saturated fat intake was associated with an increased risk of cognitive impairment (RR = 1.40; 95% CI: 1.02-1.91) and Alzheimer disease (RR: 1.87; 95% CI: 1.09-3.20) compared with the lowest category. Total and unsaturated fat intakes were not statistically associated with cognitive outcomes, showing significant between-study heterogeneity. The authors noted substantial heterogeneity in sample sizes and methodology across studies.

Shows an association, not proof of cause and effect.

Cao GY, Li M, Han L, et al. J Prev Alzheimers Dis, 2019. PMID 31062836

2019 / Umbrella review of systematic reviews, meta-analyses, and pooled analyses

Physical activity is linked to improved cognitive function and a reduced risk of cognitive impairment and dementia across the life span.

An umbrella review was conducted for the 2018 Physical Activity Guidelines for Americans Advisory Committee using systematic reviews, meta-analyses, and pooled analyses to assess physical activity's effects on cognition across the life span. Moderate evidence from randomized controlled trials indicated an association between moderate- to vigorous-intensity physical activity and cognitive improvements, including processing speed, memory, and executive function. Strong evidence demonstrated transient cognitive benefits from acute bouts of exercise post-recovery, as well as an association between greater amounts of physical activity and reduced risk of cognitive impairment, including Alzheimer's disease.

Erickson KI, Hillman C, Stillman CM, et al. Med Sci Sports Exerc, 2019. PMID 31095081

2019 / Systematic review of controlled studies

Immersive nature experiences showed positive effects across several mental, cognitive, and social health outcomes, though evidence quality was low.

A systematic review evaluated the health promotion effects of immersive nature-experiences across 133 controlled studies. Positive effects were reported for psychological wellbeing (≈55% positive of n=97), psychosocial function (≈61% positive of n=67), psychophysiological stress response (≈58% positive of n=50), cognitive performance (≈58% positive of n=36), and social skills and relationships (≈70% positive of n=34). Findings for physical health, such as cardiovascular disease risk, were less consistent (≈37% positive, ≈28% mixed, ≈35% non-significant of n=51). Across interventions and outcomes, the overall quality of the evidence was deemed low and occasionally moderate.

Mygind L, Kjeldsted E, Hartmeyer RD, et al. Front Psychol, 2019. PMID 31130890